SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 584 filers reported holding SEAGEN INC in Q2 2023. The put-call ratio across all filers is 1.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $100,760,218 | +35.8% | 474,948 | +23.2% | 0.03% | +42.1% |
| Q2 2023 | $74,194,869 | -66.5% | 385,508 | -64.8% | 0.02% | -69.4% |
| Q1 2023 | $221,526,072 | +40.4% | 1,094,118 | -10.9% | 0.06% | +34.8% |
| Q4 2022 | $157,828,400 | -15.1% | 1,228,141 | -9.7% | 0.05% | -23.3% |
| Q3 2022 | $185,998,000 | -21.4% | 1,359,342 | +1.6% | 0.06% | -16.7% |
| Q2 2022 | $236,623,000 | -2.0% | 1,337,308 | -20.2% | 0.07% | +16.1% |
| Q1 2022 | $241,386,000 | -6.0% | 1,675,718 | +0.9% | 0.06% | 0.0% |
| Q4 2021 | $256,852,000 | -4.6% | 1,661,402 | +4.7% | 0.06% | -8.8% |
| Q3 2021 | $269,344,000 | +75.8% | 1,586,239 | +63.5% | 0.07% | +78.9% |
| Q2 2021 | $153,193,000 | +8.5% | 970,314 | -4.6% | 0.04% | 0.0% |
| Q1 2021 | $141,166,000 | -23.3% | 1,016,603 | -3.3% | 0.04% | -29.6% |
| Q4 2020 | $184,047,000 | – | 1,050,847 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |